Literature DB >> 11722570

Behaviour of bovine phosphatidylethanolamine-binding protein with model membranes. Evidence of affinity for negatively charged membranes.

B S Vallée1, P Tauc, J C Brochon, R Maget-Dana, D Lelièvre, M H Metz-Boutigue, N Bureaud, F Schoentgen.   

Abstract

The ability of phosphatidylethanolamine-binding protein (PEBP) to bind membranes was tested by using small and large unilamellar vesicles and monolayers composed of l-alpha-1,2-dimyristoylphosphatidylcholine, l-alpha-1,2-dimyristoylphosphatidylglycerol and l-alpha-1,2-dimyristoylphosphatidylethanolamine. PEBP only bound to model membranes containing l-alpha-1,2-dimyristoylphosphatidylglycerol; the interaction was primarily due to electrostatic forces between the basic protein and the acidic phospholipids. Further experiments indicated that the interaction was not dependent on the length and unsaturation of the phospholipid acyl chains and was not modified by the presence of cholesterol in the membrane. PEBP affinity for negatively charged membranes is puzzling considering the previous identification of the protein as a phosphatidylethanolamine-binding protein, and suggests that the association of PEBP with phospholipid membranes is driven by a mechanism other than its binding to solubilized phosphatidylethanolamine. An explanation was suggested by its three-dimensional structure: a small cavity at the protein surface has been reported to be the binding site of the polar head of phosphatidylethanolamine, while the N-terminal and C-terminal parts of PEBP, exposed at the protein surface, appear to be involved in the interaction with membranes. To test this hypothesis, we synthesized the two PEBP terminal regions and tested them with model membranes in parallel with the whole protein. Both peptides displayed the same behaviour as whole PEBP, indicating that they could participate in the binding of PEBP to membranes. Our results strongly suggest that PEBP directly interacts with negatively charged membrane microdomains in living cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722570     DOI: 10.1046/j.0014-2956.2001.02528.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

2.  Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.

Authors:  Katharina Deiss; Caroline Kisker; Martin J Lohse; Kristina Lorenz
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

3.  Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.

Authors:  Anne N Shemon; Gary L Heil; Alexey E Granovsky; Mathew M Clark; Dan McElheny; Alexander Chimon; Marsha R Rosner; Shohei Koide
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

4.  Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism.

Authors:  Alexey E Granovsky; Matthew C Clark; Dan McElheny; Gary Heil; Jia Hong; Xuedong Liu; Youngchang Kim; Grazyna Joachimiak; Andrzej Joachimiak; Shohei Koide; Marsha Rich Rosner
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

5.  Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration.

Authors:  Ilse S Pienaar; Timothy Schallert; Suzél Hattingh; William M U Daniels
Journal:  J Neural Transm (Vienna)       Date:  2009-06-06       Impact factor: 3.575

6.  The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro.

Authors:  Chunfang Hao; Sen Wei; Zhongsheng Tong; Shufen Li; Yehui Shi; Xiaorui Wang; Zhi-hua Zhu
Journal:  Tumour Biol       Date:  2012-02-29

7.  Overexpression of Raf-1 kinase inhibitor protein inhibits cell invasion and migration in lung cancer cells through suppressing epithelial-mesenchymal transition.

Authors:  Qin Wang; Xin-Ying Li; Bing Wan; Jie Zhang; Rong Sun; Chu-Yao Zhou; Ping Zhan; Yong Song
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

Review 8.  RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity.

Authors:  Roni Touboul; Stavroula Baritaki; Apostolos Zaravinos; Benjamin Bonavida
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.